Literature DB >> 31160761

The European Medicines Agency's goals for regulatory science to 2025.

Philip A Hines, Richard H Guy, Anthony J Humphreys, Marisa Papaluca-Amati.   

Abstract

Keywords:  Drug discovery

Mesh：

Year:  2019        PMID： 31160761     DOI： 10.1038/d41573-019-00071-2

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  4 in total

1.  A future for regulatory science in the European Union: the European Medicines Agency's strategy.

Authors:  Philip A Hines; Rosanne Janssens; Rosa Gonzalez-Quevedo; Apolline I O M Lambert; Anthony J Humphreys
Journal:  Nat Rev Drug Discov       Date:  2020-05       Impact factor: 84.694

2.  Regulatory Science and Innovation Programme for Europe (ReScIPE): A proposed model.

Authors:  Philip A Hines; Richard H Guy; Angela Brand; Anthony J Humphreys; Marisa Papaluca-Amati
Journal:  Br J Clin Pharmacol       Date:  2019-10-17       Impact factor: 4.335

3.  Biomarkers in Medicines Development-From Discovery to Regulatory Qualification and Beyond.

Authors:  Natalie M Hendrikse; Jordi Llinares Garcia; Thorsten Vetter; Anthony J Humphreys; Falk Ehmann
Journal:  Front Med (Lausanne)       Date:  2022-04-26

Review 4.  Translational medicine in neuromuscular disorders: from academia to industry.

Authors:  Belinda S Cowling; Leen Thielemans
Journal:  Dis Model Mech       Date:  2019-10-24       Impact factor: 5.758
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.